Remove 2022 Remove Stroke Remove Strokes
article thumbnail

Study offers ‘compelling evidence’ for continuous stroke care improvement

American Heart News - Stroke News

Research Highlights: A retrospective look at Get With The Guidelines® - Stroke registry data from 2003 to 2022 finds substantial and sustained improvements in acute stroke care among those in the quality improvement program. Researchers found.

Stroke 129
article thumbnail

Novartis Reclaims Anthos, Reenters Factor XI Race

CardiacWire

Anthos subsequently kicked off three phase 3 trials in 2022, and wrapping up these studies by 2026 will now be Novartis responsibility. Bayer terminated its OCEANIC-AF trial for its Factor XI inhibitor, asundexian, due to 3x greater stroke (1.3% vs. 0.4%) and 4x higher ischemic stroke rates (csHR = 4.06).

AFIB 102
article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.

article thumbnail

2024 AHA/ASA Performance and Quality Measures for Spontaneous Intracerebral Hemorrhage: A Report From the American Heart Association/American Stroke Association

Stroke Journal

Stroke, Ahead of Print. The American Heart Association/American Stroke Association released a revised spontaneous intracerebral hemorrhage guideline in 2022. A working group of stroke experts reviewed this guideline and identified a subset of recommendations that were deemed suitable for creating performance measures.

article thumbnail

Atrial Fibrillation’s Downstream Consequences

CardiacWire

A BMJ study out of Denmark provided alarming new insights into atrial fibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFib heart failure and stroke prevention. The researchers analyzed 2000-2022 data from 3.5M in 2011-2022. overall, increasing from 24.2%

AFIB 105
article thumbnail

Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

Circulation

Annual inflation-adjusted (2022 US dollars) health care costs of cardiovascular risk factors are projected to triple between 2020 and 2050, from $400 billion to $1344 billion. Stroke is projected to account for the largest absolute increase in costs. Circulation, Ahead of Print.

article thumbnail

Public housing smoking ban can reduce heart attacks and strokes

Medical Xpress - Cardiology

A paper, "Evaluation of Federally Mandated Smoke-Free Housing Policy and Health Outcomes Among Adults Over the Age of 50 in Low-Income, Public Housing in New York City, 2015-2022," published in Nicotine & Tobacco Research finds that a 2018 U.S.